Source:http://linkedlifedata.com/resource/pubmed/id/10837354
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2000-7-18
|
pubmed:abstractText |
We determined the role of the multidrug resistance (MDR1) gene product, P-glycoprotein (PGP), in the secretion of aldosterone by the adrenal cell line NCI-H295. Aldosterone secretion is significantly decreased by the PGP inhibitors verapamil, cyclosporin A (CSA), PSC-833, and vinblastine. Aldosterone inhibits the efflux of the PGP substrate rhodamine 123 from NCI-H295 cells and from human mesangial cells (expressing PGP). CSA, verapamil, and the monoclonal antibody UIC2 significantly decreased the efflux of fluorescein-labeled (FL)-aldosterone microinjected into NCI-H295 cells. In MCF-7/VP cells, expressing multidrug resistance-associated protein (MRP) but not PGP, and in the parental cell line MCF7 (expressing no MRP and no PGP), the efflux of microinjected FL-aldosterone was slow. In BC19/3 cells (MCF7 cells transfected with MDR1), the efflux of FL-aldosterone was rapid and it was inhibited by verapamil, indicating that transfection with MDR1 cDNA confers the ability to transport FL-aldosterone. These results strongly indicate that PGP plays a role in the secretion of aldosterone by NCI-H295 cells and in other cells expressing MDR1, including normal adrenal cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/Oligodeoxyribonucleotides, Antisense,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein,
http://linkedlifedata.com/resource/pubmed/chemical/Rhodamine 123
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0363-6143
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
278
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
C1256-65
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10837354-Adrenal Glands,
pubmed-meshheading:10837354-Aldosterone,
pubmed-meshheading:10837354-Breast Neoplasms,
pubmed-meshheading:10837354-Cell Line,
pubmed-meshheading:10837354-Cell Membrane,
pubmed-meshheading:10837354-Drug Resistance, Multiple,
pubmed-meshheading:10837354-Etoposide,
pubmed-meshheading:10837354-Female,
pubmed-meshheading:10837354-Glomerular Mesangium,
pubmed-meshheading:10837354-Humans,
pubmed-meshheading:10837354-Oligodeoxyribonucleotides, Antisense,
pubmed-meshheading:10837354-P-Glycoprotein,
pubmed-meshheading:10837354-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:10837354-Rhodamine 123,
pubmed-meshheading:10837354-Transcription, Genetic,
pubmed-meshheading:10837354-Transfection,
pubmed-meshheading:10837354-Tumor Cells, Cultured
|
pubmed:year |
2000
|
pubmed:articleTitle |
Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells.
|
pubmed:affiliation |
Department of Internal Medicine, University of Texas Medical Branch, Galveston 77555, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|